info@tajpharma.com +91 84484 44095 / 8071 555 357

Vapi, Gujarat, India WHO-GMP Certified

WHO-GMP Certified Dolutegravir Tablets Manufacturer in India

WHO-GMP Certified

Pan-India Supply

Export Quality

Quick Inquiry

Taj Pharmaceuticals holds WHO-GMP certification for manufacturing Dolutegravir tablets, demonstrating our commitment to international quality standards. Our certification validates our manufacturing processes, quality control systems, and adherence to Good Manufacturing Practices.

Why Choose Taj Pharma?

International Quality Standards: WHO-GMP certification ensures compliance with global pharmaceutical standards.
Regular Audits: Facility undergoes periodic WHO inspections and audits.
Documentation: Complete batch documentation and traceability.
Quality Systems: Robust quality management systems in place.

Product Specifications

All products manufactured under WHO-GMP guidelines with complete documentation and quality assurance.

Manufacturing Excellence

Manufacturing Facility

WHO-GMP certified facility with validated processes, calibrated equipment, and trained personnel.

Supply & Distribution Network

Global distribution network leveraging WHO-GMP certification for international markets.

Quality Certifications

WHO-GMP

WHO-GMP

EU-GMP

EU-GMP PICs

GMP

GMP Certified

Quality

Quality Excellence

WHO-GMP certification renewed regularly with continuous compliance monitoring.

Frequently Asked Questions

WHO Good Manufacturing Practices certification ensures pharmaceutical products meet international quality standards.

WHO-GMP certification is subject to regular audits and renewal processes.

Ready to Order Dolutegravir Tablets?

Contact us today for competitive pricing and bulk order discounts

Contact Us Call Now

Related Information

Explore more about our products and services

View Products

Browse our complete range of Dolutegravir tablets and pharmaceutical products.

Get Quote

Request a competitive quote for your bulk orders with flexible payment terms.

FAQ

Find answers to frequently asked questions about our products and services.

Blog

Read articles about HIV treatment, Dolutegravir, and pharmaceutical industry updates.